Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.

Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.

Item
http://www.wikidata.org/entity/Q38533459
Review of Osteosarcoma and Current ManagementGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.The pharmacogenomics of osteosarcoma.Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.Polymorphisms of CCNB1 Associated With the Clinical Outcomes of Platinum-Based Chemotherapy in Chinese NSCLC Patients.
P2860

Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.

Item
http://www.wikidata.org/entity/Q38533459
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
@en
type
label
Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
@en
prefLabel
Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
@en
P1433
P1476
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
@en
P2860
P304
P31
P356
10.1517/17425255.2015.1060220
P407
P433
P478
P50
P577
P698